Immunology Investor Event slide image

Immunology Investor Event

Immunology Franchise Transforming the practice of medicine 26 Immunology Investor Event DUPIXENT (dupilumab) injection 300mg Lead Key Type 2 inflammatory diseases Core TAS Expand Breakthrough medicines beyond Type 2 Science driven Disrupt Transformative technologies sanofi
View entire presentation